NCT03765944View on ClinicalTrials.gov

Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

December 29, 2018

Study Completion Date

December 29, 2018

Conditions

Bioequivalence Study

Interventions

DRUG

sirolimus

SIngle administration under fasted condition

Trial Locations (1)

270 -2231

Clinique Soigner, Matsudo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Nobelpharma

INDUSTRY

NCT03765944 - Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets | Biotech Hunter | Biotech Hunter